J. Scharfstein

发表

Human C4-binding protein. I. Isolation and characterization

V. Nussenzweig, J. Scharfstein, A. Ferreira, 1978, The Journal of experimental medicine.

Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin.

J. Scharfstein, M. Leidert, A. Diehl, 2006, Journal of molecular biology.

Computer-aided quantification of microvascular networks: Application to alterations due to pathological angiogenesis in the hamster.

P. Blanco, J. Scharfstein, L. Müller, 2017, Microvascular research.

Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors

J. Scharfstein, M. Juliano, S. M. Costa, 2021, Pharmaceuticals.

Protease Activated Receptor Signaling Is Required for African Trypanosome Traversal of Human Brain Microvascular Endothelial Cells

Amanda M. Brown, K. Becker, J. Dumler, 2009, PLoS neglected tropical diseases.

Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells

J. Scharfstein, L. M. Magalhães, K. Gollob, 2010, Clinical and experimental immunology.

Congopain from Trypanosoma congolense: Drug Target and Vaccine Candidate

J. Scharfstein, F. Gauthier, G. Lalmanach, 2002, Biological chemistry.

Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro.

J. Scharfstein, L. Juliano, E. Carmona, 1992, Molecular and biochemical parasitology.

Inhibition of Trypanosomal Cysteine Proteinases by Their Propeptides*

J. Scharfstein, M. Juliano, J. Chagas, 1998, The Journal of Biological Chemistry.

Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.

E. Braunwald, C. Cannon, J. Loscalzo, 1996, The American journal of cardiology.

The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi

J. Scharfstein, Daniele Andrade, Erik Svensjö, 2013, Front. Immun..

The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.

J. Whisstock, R. Fletterick, A. Sali, 2007, Structure.

Signal That Drives Th1 Polarization Production by Dendritic Cells: A Danger Cutting Edge: Bradykinin Induces IL-12

A. Sher, J. Scharfstein, J. Viola, 2003 .

Cutting Edge: Bradykinin Induces IL-12 Production by Dendritic Cells: A Danger Signal That Drives Th1 Polarization1

A. Sher, J. Scharfstein, J. Viola, 2003, The Journal of Immunology.

Ecotin-Like ISP of L. major Promastigotes Fine-Tunes Macrophage Phagocytosis by Limiting the Pericellular Release of Bradykinin from Surface-Bound Kininogens: A Survival Strategy Based on the Silencing of Proinflammatory G-Protein Coupled Kinin B2 and B1 Receptors

J. Scharfstein, L. Juliano, Erik Svensjö, 2014, Mediators of inflammation.

Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells

J. Scharfstein, A. P. C. de A Lima, C. Sant'Anna, 2005, Journal of Cell Science.

Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides.

J. Scharfstein, L. Juliano, M. Juliano, 1997, The Biochemical journal.

Antigenicity of cystatin-binding proteins from parasitic protozoan. Detection by a proteinase inhibitor based capture immunoassay (PINC-ELISA).

J. Scharfstein, M. Abrahamson, A. Barral, 1995, Journal of immunological methods.

Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens 1

G. H. Coombs, J. Mottram, J. Scharfstein, 2003, FEBS letters.

Inhibition of cruzipain visualized in a fluorescence quenched solid‐phase inhibitor library assay. D‐Amino Acid Inhibitors for cruzipain, cathepsin B and cathepsin L

J. Scharfstein, L. Juliano, M. Juliano, 1998, Journal of peptide science : an official publication of the European Peptide Society.

The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi.

J. Scharfstein, L. Juliano, M. Juliano, 2006, FEMS microbiology letters.

Temperature-dependent substrate inhibition of the cysteine proteinase (GP57/51) from Trypanosoma cruzi.

R. Ménard, J. Scharfstein, A. C. Storer, 1992, Molecular and biochemical parasitology.

Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase.

J. Scharfstein, W. de Souza, J. A. Guimarães, 1990, Molecular and biochemical parasitology.

Identification of new cysteine protease gene isoforms in Trypanosoma cruzi.

D. Tessier, T. Vernet, J. Scharfstein, 1994, Molecular and biochemical parasitology.

Subverting bradykinin-evoked inflammation by co-opting the contact system: lessons from survival strategies of Trypanosoma cruzi

J. Scharfstein, 2018, Current opinion in hematology.

Mast Cell Coupling to the Kallikrein–Kinin System Fuels Intracardiac Parasitism and Worsens Heart Pathology in Experimental Chagas Disease

J. Scharfstein, L. Juliano, Daniele Andrade, 2017, Front. Immunol..

G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.

J. Scharfstein, M. Barral-Netto, P. I. Ramos, 2017, Advances in immunology.

Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy

J. Scharfstein, Daniele Andrade, H. Tanowitz, 2012, British journal of pharmacology.

Infection-associated vasculopathy in experimental chagas disease pathogenic roles of endothelin and kinin pathways.

J. Scharfstein, Daniele Andrade, 2011, Advances in parasitology.

Trypanosoma cruzi Cysteine Proteases, Acting at the Interface Between the Vascular and Immune Systems, Influence Pathogenic Outcome in Experimental Chagas Disease

J. Scharfstein, 2010 .

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.

J. Scharfstein, R. Corrêa-Oliveira, J. Gomes, 2009, Memorias do Instituto Oswaldo Cruz.

Role of vasoactive mediators in the pathogenesis of Chagas' disease.

J. Scharfstein, L. Weiss, H. Tanowitz, 2003, Frontiers in bioscience : a journal and virtual library.

20 The kallikrein-kinin system in parasitic infections

J. Scharfstein, Erik Svensjö, 2011 .

Cooperative Activation of TLR2 and Bradykinin B2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi1

I. C. Almeida, J. Scharfstein, R. Gazzinelli, 2006, The Journal of Immunology.

Bradykinin B2 Receptors of Dendritic Cells, Acting as Sensors of Kinins Proteolytically Released by Trypanosoma cruzi, Are Critical for the Development of Protective Type-1 Responses

J. Scharfstein, Fnu Nagajyothi, H. Tanowitz, 2007, PLoS pathogens.

Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor subtypes (B1/B2)

J. Stewart, J. Scharfstein, Daniele Andrade, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Host Cell Invasion by TRYPANOSOMA cRUZI Is Potentiated by Activation of Bradykinin B2 Receptors

J. Scharfstein, L. Juliano, W. Müller-Esterl, 2000, The Journal of experimental medicine.

Kininogens Coordinate Adaptive Immunity through the Proteolytic Release of Bradykinin, an Endogenous Danger Signal Driving Dendritic Cell Maturation

J. Scharfstein, Erik Svensjö, A. Granato, 2007, Scandinavian journal of immunology.

Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway

J. Scharfstein, Erik Svensjö, V. Schmitz, 2008, Biological chemistry.

Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi.

J. Scharfstein, A. Lima, 2008, Sub-cellular biochemistry.

Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll‐like 2 receptors

J. Scharfstein, M. Teixeira, Erik Svensjö, 2009, Journal of leukocyte biology.

Cloning and characterization of the phosphoglucomutase of Trypanosoma cruzi and functional complementation of a Saccharomyces cerevisiae PGM null mutant.

J. Scharfstein, N. Heise, L. Mendonça-Previato, 2005, Glycobiology.

Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis

J. Scharfstein, S. Nagashima, L. de Noronha, 2020, Frontiers in Immunology.

A role for extracellular amastigotes in the immunopathology of Chagas disease.

J. Scharfstein, A. Morrot, 1999, Memorias do Instituto Oswaldo Cruz.

HMGB1 correlates with severity and death of COVID-19 patients

J. Scharfstein, M. Fantappié, A. C. Oliveira, 2022, medRxiv.

P2X7 receptor-mediated leukocyte recruitment and Porphyromonas gingivalis clearance requires IL-1β production and autocrine IL-1 receptor activation.

J. Scharfstein, D. Ojcius, Kívia Queiroz de Andrade, 2019, Immunobiology.

Bradykinin enhances Sindbis virus infection in human brain microvascular endothelial cells.

J. Scharfstein, E. Marques, N. M. Rust, 2012, Virology.

Intramucosally with IL-17-Producing T Cells in Mice Infected-and γ Fimbriae-Specific IFN-Released by Gingipain Induce Kinin Danger Signals Proteolytically

J. Scharfstein, J. Potempa, K. Nguyen, 2009 .

Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.

J. Scharfstein, M. Abrahamson, M. Vannier-Santos, 2001, Journal of cell science.

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

J. Stamler, J. Loscalzo, J. Scharfstein, 1994, The Journal of clinical investigation.

Cooperative Activation of TLR 2 and Bradykinin B 2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi 1

I. C. Almeida, J. Scharfstein, R. Gazzinelli, 2006 .

Trypanosoma cruzi Model of Subcutaneous Infection by Induction of Type 1 Immunity in a Mouse Receptor Is Required for 2 Bradykinin B Cooperative Activation of TLR 2 and

Adriana, I. C. Almeida, J. Scharfstein, 2006 .

Contents Vol. 6, 2014

V. Nizet, Erliang Zeng, K. Ley, 2014, Journal of Innate Immunity.

Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.

J. Scharfstein, M. Teixeira, M. Bozza, 2012, Microvascular research.

Trypanosoma Regulates Innate and Adaptive Immunity in C5a and Bradykinin Receptor Cross-Talk

J. Scharfstein, J. Köhl, L. N. Almeida, 2014 .

Signal transduction inTrypanosoma cruzi: opposite effects of adenylcyclase and phospholipase C systems in growth control

E. Rondinelli, J. Scharfstein, M. M. Oliveira, 1993, Molecular and Cellular Biochemistry.

Recent Developments in the Pathology of Chagas Disease with Emphasis on the Cardiovascular System

J. Scharfstein, S. Factor, H. Tanowitz, 2003 .

Further characterization ofTrypanosoma cruzi GP57/51 as the major antigen expressed by differentiating epimastigotes

J. Scharfstein, S. Goldenberg, M. Bonaldo, 2004, Parasitology Research.

Heparan Sulfate Modulates Kinin Release by Trypanosoma cruzi through the Activity of Cruzipain*

A. Schmaier, J. Scharfstein, L. Juliano, 2002, The Journal of Biological Chemistry.

Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.

R. Ménard, T. Vernet, J. Scharfstein, 2001, Molecular and biochemical parasitology.

Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.

J. Scharfstein, M. Juliano, F. Gauthier, 1999, European journal of biochemistry.

Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.

J. Scharfstein, L. Juliano, M. Juliano, 1996, The Biochemical journal.

Salivary Gland Homogenates of Lutzomyia longipalpis and Its Vasodilatory Peptide Maxadilan Cause Plasma Leakage via PAC1 Receptor Activation

J. Scharfstein, M. Bozza, E. Saraiva, 2009, Journal of Vascular Research.

A New Cruzipain-Mediated Pathway of Human Cell Invasion by Trypanosoma cruzi Requires Trypomastigote Membranes

J. Scharfstein, A. Lima, Isabela M Aparicio, 2004, Infection and Immunity.

Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.

J. Scharfstein, L. Juliano, M. Vannier-Santos, 2000, Molecular and biochemical parasitology.

Kininogenase Activity by the Major Cysteinyl Proteinase (Cruzipain) from Trypanosoma cruzi *

J. Scharfstein, L. Juliano, M. Juliano, 1997, The Journal of Biological Chemistry.

Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex.

M. Mori, J. Scharfstein, P. R. Batista, 2006, Microbes and infection.

Effect of antihypertensive therapy with angiotensin-converting enzyme inhibitors on chronic periodontitis: a case-control study.

J. Scharfstein, R. Luiz, D. Barbirato, 2016, Oral diseases.

Kinin Danger Signals Proteolytically Released by Gingipain Induce Fimbriae-Specific IFN-γ- and IL-17-Producing T Cells in Mice Infected Intramucosally with Porphyromonas gingivalis1

J. Scharfstein, J. Potempa, K. Nguyen, 2009, The Journal of Immunology.

Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.

J. Scharfstein, A. P. C. de A Lima, J. Lonsdale-Eccles, 2006, The Journal of clinical investigation.

Novel Family of Insect Salivary Inhibitors Blocks Contact Pathway Activation by Binding to Polyphosphate, Heparin, and Dextran Sulfate

J. Andersen, J. Ribeiro, J. Scharfstein, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors

J. Scharfstein, A. Morrot, D. Feijó, 2012, Parasites & Vectors.

Chemical structure and antigenic aspects of complexes obtained from epimastigotes of Trypanosoma cruzi.

J. Scharfstein, P. Gorin, L. Mendonça-Previato, 1983, Biochemistry.

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

J. Stamler, J. Loscalzo, J. Scharfstein, 1993, The Journal of clinical investigation.

C5a and Bradykinin Receptor Cross-Talk Regulates Innate and Adaptive Immunity in Trypanosoma cruzi Infection

J. Scharfstein, J. Köhl, L. N. Almeida, 2014, The Journal of Immunology.

Infection Trypanosoma cruzi Regulates Innate and Adaptive Immunity in C5a and Bradykinin Receptor Cross-Talk

J. Scharfstein, J. Köhl, L. N. Almeida, 2014 .

P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation

H. Ulrich, J. Scharfstein, M. Ratajczak, 2021, Stem cell reviews and reports.

Porphyromonas gingivalis Fimbriae Dampen P2X7-Dependent Interleukin-1β Secretion

J. Scharfstein, D. Ojcius, J. Potempa, 2014, Journal of Innate Immunity.

A recombinant form of chagasin from Trypanosoma cruzi: inhibitory activity on insect cysteine proteinases.

J. Scharfstein, M. F. Grossi-de-Sá, J. W. A. Valencia, 2008, Pest management science.

Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies.

J. Scharfstein, W. de Souza, L. Mendonça-Previato, 1983, Journal of immunology.

A Dual Role for P2X7 Receptor during Porphyromonas gingivalis Infection

J. Scharfstein, D. Ojcius, J. Potempa, 2015, Journal of dental research.

Role of chagasin-like inhibitors as endogenous regulators of cysteine proteases in parasitic protozoa

J. Scharfstein, Camila C. Santos, Ana Paula C. A. Lima, 2006, Parasitology Research.

Chagas' disease: serodiagnosis with purified Gp25 antigen.

J. Scharfstein, L. Mendonça-Previato, A. Rassi, 1985, The American journal of tropical medicine and hygiene.

Dietary Fiber Drives IL-1β–Dependent Peritonitis Induced by Bacteroides fragilis via Activation of the NLRP3 Inflammasome

C. Mackay, J. Scharfstein, L. Lobo, 2021, The Journal of Immunology.

Trypanosoma cruzi: characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes.

J. Scharfstein, M. Miles, M. Schechter, 1986, Journal of immunology.

Human C4-binding protein. Association with immune complexes in vitro and in vivo.

V. Nussenzweig, J. Scharfstein, G. Gallo, 1979, The Journal of clinical investigation.

Induction of the acute-phase protein serum amyloid P in experimental Chagas' disease

J. Scharfstein, M. Barcinski, L. Leon, 1982, Infection and immunity.

Parasite cysteine proteinase interactions with alpha 2-macroglobulin or kininogens: differential pathways modulating inflammation and innate immunity in infection by pathogenic trypanosomatids.

J. Scharfstein, 2006, Immunobiology.

Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.

S. Reed, J. Scharfstein, A. Lima, 1993, Journal of immunology.

Immunogenicity of Trypanosoma cruzi cysteine proteinase.

J. Scharfstein, A. Arnholdt, 1991, Research in immunology.

The propeptide of cruzipain − a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F

R. Ménard, T. Sulea, J. Scharfstein, 2007, The FEBS journal.

Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease

J. Scharfstein, R. Gazzinelli, G. Gazzinelli, 1990, Infection and immunity.

Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.

J. Scharfstein, D. Hoft, C. Eickhoff, 2002, Microbes and infection.

Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.

J. Scharfstein, D. Strickland, A. Morrot, 1997, International immunology.

Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.

J. Scharfstein, R. Gazzinelli, L. Galvão, 1993, The American journal of tropical medicine and hygiene.

Glycoprotein GP57/51 of Trypanosoma cruzi: structural and conformational epitopes defined with monoclonal antibodies.

J. Scharfstein, L. Travassos, A. C. Murta, 1988, Memorias do Instituto Oswaldo Cruz.

Perspectives on the Trypanosoma cruzi–host cell receptor interactions

Huan Huang, J. Scharfstein, M. Lima, 2009, Parasitology Research.

Brazilian immunology in Caxambu: beyond vaccination, a tribute to the pioneers of basic research in Chagas disease

J. Scharfstein, 2022, Memorias do Instituto Oswaldo Cruz.

Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway

P. Blanco, I. C. Almeida, J. Scharfstein, 2022, Pathogens.

Oral infection of mice with Fusobacterium nucleatum results in macrophage recruitment to the dental pulp and bone resorption

J. Scharfstein, D. Ojcius, C. Takiya, 2018, Biomedical journal.

Molecular approaches to antithrombotic therapy.

J. Loscalzo, J. Scharfstein, 1992, Hospital practice.

Proteasome activity is required for the stage-specific transformation of a protozoan parasite

E. Corey, V. Nussenzweig, J. Scharfstein, 1996, The Journal of experimental medicine.

Interactions between CD3 and Thy1 T cell activation pathways: blockade of CD3-mediated T lymphocyte activation induced by immobilized anti-Thy1 antibodies.

J. Scharfstein, M. Bellio, G. A. dos Reis, 1991, Cellular immunology.

Presence of a C4-Binding Protein (C4-bp) in Human Serum

V. Nussenzweig, J. Scharfstein, I. Gigli, 1978 .

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy

J. Scharfstein, Daniele Andrade, J. Pesquero, 2023, Journal of clinical medicine.

Comparison of the specificity, stability and individual rate constants with respective activation parameters for the peptidase activity of cruzipain and its recombinant form, cruzain, from Trypanosoma cruzi.

J. Scharfstein, L. Juliano, M. Juliano, 2001, European journal of biochemistry.

Protective effect of Chromobacterium violaceum and violacein against bone resorption by periodontitis

J. Scharfstein, C. Takiya, M. Fogacci, 2023, Clinical Oral Investigations.

High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID‐19 patients: HMGB1 as a biomarker of worst prognosis

J. Scharfstein, S. P. C. Barroso, R. Vianna-Jorge, 2023, Clinical and translational science.

P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation

H. Ulrich, J. Scharfstein, M. Ratajczak, 2021, Stem Cell Reviews and Reports.

Kinins Released by Erythrocytic Stages of Plasmodium falciparum Enhance Adhesion of Infected Erythrocytes to Endothelial Cells and Increase Blood Brain Barrier Permeability via Activation of Bradykinin Receptors

J. Scharfstein, C. Caruso-Neves, A. Pinheiro, 2019, Front. Med..

The role of conserved residues of chagasin in the inhibition of cysteine peptidases

G. H. Coombs, J. Mottram, Brian O. Smith, 2008, FEBS letters.

Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs

P. Blanco, J. Scharfstein, C. Bulant, 2023, Frontiers in Immunology.

Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy

J. Scharfstein, Daniele Andrade, H. Tanowitz, 2012, British journal of pharmacology.

Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells

J. Scharfstein, L. M. Magalhães, K. Gollob, 2010, Clinical and experimental immunology.

ASSOCIATION WITH IMMUNE COMPLEXES IN VITRO AND IN VIVO

V. Nussenzweig, J. Scharfstein, G. Gallo, 1979 .

Trypanosoma cruzi: identification of a membrane cysteine proteinase linked through a GPI anchor.

J. Scharfstein, M. Fresno, C. Hernández-Munain, 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease (Journal of Clinical Investigation (2006) 116, (2739-2747) DOI: 10.1172/JCI27798)

J. Scharfstein, A. Lima, J. Lonsdale-Eccles, 2008 .

IL‐18R signaling is required for γδ T cell response and confers resistance to Trypanosoma cruzi infection

J. Scharfstein, M. Bellio, J. Echevarria-Lima, 2020, Journal of leukocyte biology.